Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Immunity & Ageing
Published in: Immunity & Ageing 1/2008

Open Access 01-12-2008 | Review

Immunity, ageing and cancer

Authors: Evelyna Derhovanessian, Rafael Solana, Anis Larbi, Graham Pawelec

Published in: Immunity & Ageing | Issue 1/2008

Login to get access

Abstract

Compromised immunity contributes to the decreased ability of the elderly to control infectious disease and to their generally poor response to vaccination. It is controversial as to how far this phenomenon contributes to the well-known age-associated increase in the occurrence of many cancers in the elderly. However, should the immune system be important in controlling cancer, for which there is a great deal of evidence, it is logical to propose that dysfunctional immunity in the elderly would contribute to compromised immunosurveillance and increased cancer occurrence. The chronological age at which immunosenescence becomes clinically important is known to be influenced by many factors, including the pathogen load to which individuals are exposed throughout life. It is proposed here that the cancer antigen load may have a similar effect on "immune exhaustion" and that pathogen load and tumor load may act additively to accelerate immunosenescence. Understanding how and why immune responsiveness changes in humans as they age is essential for developing strategies to prevent or restore dysregulated immunity and assure healthy longevity, clearly possible only if cancer is avoided. Here, we provide an overview of the impact of age on human immune competence, emphasizing T-cell-dependent adaptive immunity, which is the most sensitive to ageing. This knowledge will pave the way for rational interventions to maintain or restore appropriate immune function not only in the elderly but also in the cancer patient.
Appendix
Available only for authorised users
Literature
1.
Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK: Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist. 2003, 8: 541-52.PubMedCrossRef
2.
Serrano M, Blasco MA: Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol. 2007, 8: 715-22.PubMedCrossRef
3.
Finkel T, Serrano M, Blasco MA: The common biology of cancer and ageing. Nature. 2007, 448: 767-74.PubMedCrossRef
4.
Finn OJ: Human tumor antigens, immunosurveillance, and cancer vaccines. Immunol Res. 2006, 36: 73-82.PubMedCrossRef
5.
Smyth MJ, Dunn GP, Schreiber RD: Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol. 2006, 90: 1-50.PubMedCrossRef
6.
7.
Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P: Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood. 2000, 95: 2860-8.PubMed
8.
Lazuardi L, Jenewein B, Wolf AM, Pfister G, Tzankov A, Grubeck-Loebenstein B: Age-related loss of naive T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology. 2005, 114: 37-43.PubMedCentralPubMedCrossRef
9.
Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G: Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing. 2008, 5: 6-PubMedCentralPubMedCrossRef
10.
Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, Witkowski J, Fulbright J, Weyand CM, Goronzy JJ: The influence of age on T cell generation and TCR diversity. J Immunol. 2005, 174: 7446-52.PubMedCrossRef
11.
Hadrup SR, Strindhall J, Kollgaard T, Seremet T, Johansson B, Pawelec G, Thor SP, Wikby A: Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol. 2006, 176: 2645-53.PubMedCrossRef
12.
Zinkernagel RM, Moskophidis D, Kundig T, Oehen S, Pircher H, Hengartner H: Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol Rev. 1993, 133: 199-223.PubMedCrossRef
13.
14.
Weksler ME, Goodhardt M, Szabo P: The effect of age on B cell development and humoral immunity. Springer Semin Immunopathol. 2002, 24: 35-52.PubMedCrossRef
15.
Ogata K, An E, Shioi Y, Nakamura K, Luo S, Yokose N, Minami S, Dan K: Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol. 2001, 124: 392-7.PubMedCentralPubMedCrossRef
16.
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S: Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007, 128: 92-105.PubMedCrossRef
17.
Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B: Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med. 2007, 9: 1-17.PubMedCrossRef
18.
Ouyang Q, Wagner WM, Wikby A, Walter S, Aubert G, Dodi AI, Travers P, Pawelec G: Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol. 2003, 23: 247-57.PubMedCrossRef
19.
Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A: Human immunosenescence: is it infectious?. Immunol Rev. 2005, 205: 257-68.PubMedCrossRef
20.
Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss PA: Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002, 169: 1984-92.PubMedCrossRef
21.
Looney RJ, Falsey A, Campbell D, Torres A, Kolassa J, Brower C, McCann R, Menegus M, McCormick K, Frampton M, Hall W, Abraham GN: Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol. 1999, 90: 213-9.PubMedCrossRef
22.
Vasto S, Colonna-Romano G, Larbi A, Wikby A, Caruso C, Pawelec G: Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing. 2007, 4: 2-PubMedCentralPubMedCrossRef
23.
24.
25.
Nijnik A, Woodbine L, Marchetti C, Dawson S, Lambe T, Liu C, Rodrigues NP, Crockford TL, Cabuy E, Vindigni A, Enver T, Bell JI, Slijepcevic P, Goodnow CC, Jeggo PA, Cornall RJ: DNA repair is limiting for haematopoietic stem cells during ageing. Nature. 2007, 447: 686-90.PubMedCrossRef
26.
Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL: Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature. 2007, 447: 725-9.PubMedCrossRef
27.
Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, Weissman IL: Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA. 2005, 102: 9194-9.PubMedCentralPubMedCrossRef
28.
Cho RH, Sieburg HB, Muller-Sieburg CE: A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood. 2008, 111: 5553-61.PubMedCentralPubMedCrossRef
29.
Tsuboi I, Morimoto K, Hirabayashi Y, Li GX, Aizawa S, Mori KJ, Kanno J, Inoue T: Senescent B lymphopoiesis is balanced in suppressive homeostasis: decrease in interleukin-7 and transforming growth factor-beta levels in stromal cells of senescence-accelerated mice. Exp Biol Med (Maywood). 2004, 229: 494-502.
30.
Zediak VP, Maillard I, Bhandoola A: Multiple prethymic defects underlie age-related loss of T progenitor competence. Blood. 2007
31.
32.
Wheeler CJ, Black KL, Liu G, Ying H, Yu JS, Zhang W, Lee PK: Thymic CD8+ T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality. J Immunol. 2003, 171: 4927-33.PubMedCrossRef
33.
Hakim FT, Memon SA, Cepeda R, Jones EC, Chow CK, Kasten-Sportes C, Odom J, Vance BA, Christensen BL, Mackall CL, Gress RE: Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest. 2005, 115: 930-9.PubMedCentralPubMedCrossRef
34.
Steinmann GG, Klaus B, Muller-Hermelink HK: The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol. 1985, 22: 563-75.PubMedCrossRef
35.
Sutherland JS, Goldberg GL, Hammett MV, Uldrich AP, Berzins SP, Heng TS, Blazar BR, Millar JL, Malin MA, Chidgey AP, Boyd RL: Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol. 2005, 175: 2741-53.PubMedCrossRef
36.
Heng TS, Goldberg GL, Gray DH, Sutherland JS, Chidgey AP, Boyd RL: Effects of castration on thymocyte development in two different models of thymic involution. J Immunol. 2005, 175: 2982-93.PubMedCrossRef
37.
Miller JP, Allman D: The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol. 2003, 171: 2326-30.PubMedCrossRef
38.
Min H, Montecino-Rodriguez E, Dorshkind K: Reduction in the developmental potential of intrathymic T cell progenitors with age. J Immunol. 2004, 173: 245-50.PubMedCrossRef
39.
Gruver AL, Sempowski GD: Cytokines, leptin, and stress-induced thymic atrophy. J Leukoc Biol. 2008
40.
Lung TL, Saurwein-Teissl M, Parson W, Schonitzer D, Grubeck-Loebenstein B: Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine. 2000, 18: 1606-12.PubMedCrossRef
41.
Della-Bella S, Bierti L, Presicce P, Arienti R, Valenti M, Saresella M, Vergani C, Villa ML: Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol. 2007, 122: 220-8.PubMedCrossRef
42.
Aydar Y, Balogh P, Tew JG, Szakal AK: Follicular dendritic cells in aging, a "bottle-neck" in the humoral immune response. Ageing Res Rev. 2004, 3: 15-29.PubMedCrossRef
43.
44.
Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S: Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol. 2007, 178: 6912-22.PubMedCrossRef
45.
Ramakrishnan R, Antonia S, Gabrilovich DI: Combined modality immunotherapy and chemotherapy: a new perspective. Cancer Immunol Immunother. 2008, 57: 1523-9.PubMedCrossRef
46.
De Rosa SC, Andrus JP, Perfetto SP, Mantovani JJ, Herzenberg LA, Herzenberg LA, Roederer M: Ontogeny of gamma delta T cells in humans. J Immunol. 2004, 172: 1637-45.PubMedCrossRef
47.
Halary F, Pitard V, Dlubek D, Krzysiek R, de la SH, Merville P, Dromer C, Emilie D, Moreau JF, chanet-Merville J: Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J Exp Med. 2005, 201: 1567-78.PubMedCentralPubMedCrossRef
48.
Caccamo N, Dieli F, Wesch D, Jomaa H, Eberl M: Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells. J Leukoc Biol. 2006, 79: 663-6.PubMedCrossRef
49.
Argentati K, Re F, Donnini A, Tucci MG, Franceschi C, Bartozzi B, Bernardini G, Provinciali M: Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians. J Leukoc Biol. 2002, 72: 65-71.PubMed
50.
Re F, Poccia F, Donnini A, Bartozzi B, Bernardini G, Provinciali M: Skewed representation of functionally distinct populations of Vgamma9Vdelta2 T lymphocytes in aging. Exp Gerontol. 2005, 40: 59-66.PubMedCrossRef
51.
Colonna-Romano G, Aquino A, Bulati M, Lio D, Candore G, Oddo G, Scialabba G, Vitello S, Caruso C: Impairment of gamma/delta T lymphocytes in elderly: implications for immunosenescence. Exp Gerontol. 2004, 39: 1439-46.PubMedCrossRef
52.
Rivnay B, Bergman S, Shinitzky M, Globerson A: Correlations between membrane viscosity, serum cholesterol, lymphocyte activation and aging in man. Mech Ageing Dev. 1980, 12: 119-26.PubMedCrossRef
53.
Larbi A, Grenier A, Frisch F, Douziech N, Fortin C, Carpentier AC, Fulop T: Acute in vivo elevation of intravascular triacylglycerol lipolysis impairs peripheral T cell activation in humans. Am J Clin Nutr. 2005, 82: 949-56.PubMed
54.
Larbi A, Dupuis G, Khalil A, Douziech N, Fortin C, Fulop T: Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging. Cell Signal. 2006, 18: 1017-30.PubMedCrossRef
55.
Ray A, Sharma BK, Bahadur AK, Pasha ST, Bhadola P, Murthy NS: Serum lipid profile and its relationship with host immunity in carcinomas of the breast and uterine cervix. Tumori. 1997, 83: 943-7.PubMed
56.
Hager MH, Solomon KR, Freeman MR: The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care. 2006, 9: 379-85.PubMedCrossRef
57.
Fulop T, Gagne D, Goulet AC, Desgeorges S, Lacombe G, Arcand M, Dupuis G: Age-related impairment of p56lck and ZAP-70 activities in human T lymphocytes activated through the TcR/CD3 complex. Exp Gerontol. 1999, 34: 197-216.PubMedCrossRef
58.
Effros RB, Boucher N, Porter V, Zhu X, Spaulding C, Walford RL, Kronenberg M, Cohen D, Schachter F: Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol. 1994, 29: 601-9.PubMedCrossRef
59.
Pawelec G, Rehbein A, Haehnel K, Merl A, Adibzadeh M: Human T-cell clones in long-term culture as a model of immunosenescence. Immunol Rev. 1997, 160: 31-42.PubMedCrossRef
60.
Bryl E, Vallejo AN, Weyand CM, Goronzy JJ: Down-regulation of CD28 expression by TNF-alpha. J Immunol. 2001, 167: 3231-8.PubMedCrossRef
61.
Warrington KJ, Vallejo AN, Weyand CM, Goronzy JJ: CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation. Blood. 2003, 101: 3543-9.PubMedCrossRef
62.
63.
Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, Pena J, Solana R: Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev. 2000, 121: 77-88.PubMedCrossRef
64.
Mazzatti DJ, White A, Forsey RJ, Powell JR, Pawelec G: Gene expression changes in long-term culture of T-cell clones: genomic effects of chronic antigenic stress in aging and immunosenescence. Aging Cell. 2007, 6: 155-63.PubMedCentralPubMedCrossRef
65.
Tewari K, Walent J, Svaren J, Zamoyska R, Suresh M: Differential requirement for Lck during primary and memory CD8+ T cell responses. Proc Natl Acad Sci USA. 2006, 103: 16388-93.PubMedCentralPubMedCrossRef
66.
Lanzavecchia A, Sallusto F: Understanding the generation and function of memory T cell subsets. Curr Opin Immunol. 2005, 17: 326-32.PubMedCrossRef
67.
Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM: Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol. 1998, 16: 743-7.PubMedCrossRef
68.
Weng NP, Palmer LD, Levine BL, Lane HC, June CH, Hodes RJ: Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev. 1997, 160: 43-54.PubMedCrossRef
69.
Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM, Corthesy P, Devevre E, Speiser DE, Rufer N: Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol. 2007, 178: 4112-9.PubMedCrossRef
70.
Effros RB, Pawelec G: Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion?. Immunol Today. 1997, 18: 450-4.PubMedCrossRef
71.
Pawelec G, Sansom D, Rehbein A, Adibzadeh M, Beckman I: Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones. Exp Gerontol. 1996, 31: 655-68.PubMedCrossRef
72.
Spaulding C, Guo W, Effros RB: Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol. 1999, 34: 633-44.PubMedCrossRef
73.
Izaks GJ, Remarque EJ, Becker SV, Westendorp RG: Lymphocyte count and mortality risk in older persons. The Leiden 85-Plus Study. J Am Geriatr Soc. 2003, 51: 1461-5.PubMedCrossRef
74.
Vukmanovic-Stejic M, Zhang Y, Cook JE, Fletcher JM, McQuaid A, Masters JE, Rustin MH, Taams LS, Beverley PC, Macallan DC, Akbar AN: Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest. 2006, 116: 2423-33.PubMedCentralPubMedCrossRef
75.
Wallace DL, Zhang Y, Ghattas H, Worth A, Irvine A, Bennett AR, Griffin GE, Beverley PC, Tough DF, Macallan DC: Direct measurement of T cell subset kinetics in vivo in elderly men and women. J Immunol. 2004, 173: 1787-94.PubMedCrossRef
76.
Macallan DC, Wallace DL, Zhang Y, Ghattas H, Asquith B, de LC, Worth A, Panayiotakopoulos G, Griffin GE, Tough DF, Beverley PC: B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood. 2005, 105: 3633-40.PubMedCrossRef
77.
Zhang Y, Wallace DL, de Lara CM, Ghattas H, Asquith B, Worth A, Griffin GE, Taylor GP, Tough DF, Beverley PC, Macallan DC: In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology. 2007, 121: 258-65.PubMedCentralPubMedCrossRef
78.
Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CFJE: Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 2008
79.
Plunkett FJ, Franzese O, Finney HM, Fletcher JM, Belaramani LL, Salmon M, Dokal I, Webster D, Lawson AD, Akbar AN: The loss of telomerase activity in highly differentiated CD8+CD28-. J Immunol. 2007, 178: 7710-9.PubMedCrossRef
80.
81.
Pawelec G, Schneider EM, Wernet P: Acquisition of suppressive activity and natural killer-like cytotoxicity by human alloproliferative "helper" T cell clones. J Immunol. 1986, 136: 402-11.PubMed
82.
83.
84.
Weinberger B, Lazuardi L, Weiskirchner I, Keller M, Neuner C, Fischer KH, Neuman B, Wurzner R, Grubeck-Loebenstein B: Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol. 2007, 68: 86-90.PubMedCrossRef
85.
Ouyang Q, Wagner WM, Walter S, Muller CA, Wikby A, Aubert G, Klatt T, Stevanovic S, Dodi T, Pawelec G: An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev. 2003, 124: 477-85.PubMedCrossRef
86.
Appay V, Almeida JR, Sauce D, Autran B, Papagno L: Accelerated immune senescence and HIV-1 infection. Exp Gerontol. 2007, 42: 432-7.PubMedCrossRef
87.
Weyand CM, Fulbright JW, Goronzy JJ: Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp Gerontol. 2003, 38: 833-41.PubMedCrossRef
88.
Boren E, Gershwin ME: Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev. 2004, 3: 401-6.PubMedCrossRef
89.
Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM: Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol. 2001, 75: 12182-7.PubMedCentralPubMedCrossRef
90.
McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, Ewen C, Kane KP, Bleackley RC: T cell responses are better correlates of vaccine protection in the elderly. J Immunol. 2006, 176: 6333-9.PubMedCrossRef
91.
Murasko DM, Jiang J: Response of aged mice to primary virus infections. Immunol Rev. 2005, 205: 285-96.PubMedCrossRef
92.
Ouyang Q, Wagner WM, Voehringer D, Wikby A, Klatt T, Walter S, Muller CA, Pircher H, Pawelec G: Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol. 2003, 38: 911-20.PubMedCrossRef
93.
Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Lofgren S, Nilsson BO, Ernerudh J, Pawelec G, Johansson B: An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci. 2005, 60: 556-65.PubMedCrossRef
94.
Messaoudi I, Warner J, Nikolich-Zugich D, Fischer M, Nikolich-Zugich J: Molecular, cellular, and antigen requirements for development of age-associated T cell clonal expansions in vivo. J Immunol. 2006, 176: 301-8.PubMedCrossRef
95.
Pawelec G, Koch S, Griesemann H, Rehbein A, Hahnel K, Gouttefangeas C: Immunosenescence, suppression and tumour progression. Cancer Immunol Immunother. 2006, 55: 981-6.PubMedCrossRef
96.
Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G: Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda). 2008, 23: 64-74.CrossRef
97.
Fulop T, Larbi A, Hirokawa K, Mocchegiani E, Lesourds B, Castle S, Wikby A, Franceschi C, Pawelec G: Immunosupportive therapies in aging. Clin Interv Aging. 2007, 2: 33-54.PubMedCentralPubMedCrossRef
98.
Pawelec G, Koch S, Gouttefangeas C, Wikby A: Immunorejuvenation in the elderly. Rejuvenation Res. 2006, 9: 111-6.PubMedCrossRef
99.
Mocchegiani E, Malavolta M, Marcellini F, Pawelec G: Zinc, oxidative stress, genetic background and immunosenescence: implications for healthy ageing. Immun Ageing. 2006, 3: 6-PubMedCentralPubMedCrossRef
100.
Neri S, Pawelec G, Facchini A, Ferrari C, Mariani E: Altered expression of mismatch repair proteins associated with acquisition of microsatellite instability in a clonal model of human T lymphocyte aging. Rejuvenation Res. 2008, 11: 565-72.PubMedCrossRef
101.
Larbi A, Fulop T, Pawelec G: Immune receptor signalling, aging and autoimmunity. Multichain immune recognition receptor signalling: from spatiotemporal organisation to human disease. Edited by: Sigalov AB. 2007, Landes Bioscience, 781-92.
102.
DelaRosa O, Pawelec G, Peralbo E, Wikby A, Mariani E, Mocchegiani E, Tarazona R, Solana R: Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology. 2006, 7: 471-81.PubMedCrossRef
103.
Derhovanessian E, Gouttefangeas C, Koch S, Pawelec G: Monitoring T cell responses to immunotherapy: can we now identify biomarkers predicting patients who will be responders. Current Cancer Therapy Rev. 2008, 4: 111-9.CrossRef
104.
Walter S, Bioley G, Buhring HJ, Koch S, Wernet D, Zippelius A, Pawelec G, Romero P, Stevanovic S, Rammensee HG, Gouttefangeas C: High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors. Eur J Immunol. 2005, 35: 2876-85.PubMedCrossRef
105.
Hirokawa K, Utsuyama M, Ishikawa T, Kikuchi Y, Kitagawa M, Fujii Y, Nariuchi H, Uetake H, Sugihara K: Decline of T cell-related immune functions in cancer patients and an attempt to restore them through infusion of activated autologous T cells. Mech Ageing Dev. 2008
106.
So T, Hanagiri T, Chapiro J, Colau D, Brasseur F, Yasumoto K, Boon T, Coulie PG: Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195–203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules. Cancer Immunol Immunother. 2007, 56: 259-69.PubMedCrossRef
107.
Gravekamp C, Kim SH, Castro F: Cancer vaccination: Manipulation of immune responses at old age. Mech Ageing Dev. 2008
108.
109.
Vasto S, Carruba G, Lio D, Colonna-Romano G, Di BD, Candore G, Caruso C: Inflammation, ageing and cancer. Mech Ageing Dev. 2008
110.
Salvioli S, Capri M, Bucci L, Lanni C, Racchi M, Uberti D, Memo M, Mari D, Govoni S, Franceschi C: Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol Immunother. 2008
111.
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, Andre F, Delaloge S, Tursz T, Kroemer G, Zitvogel L: Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007, 13: 1050-9.PubMedCrossRef
112.
Balducci L, Ershler WB: Cancer and ageing: a nexus at several levels. Nat Rev Cancer. 2005, 5: 655-62.PubMedCrossRef
113.
Sharma S, Dominguez AL, Hoelzinger DB, Lustgarten J: CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged. Cancer Immunol Immunother. 2008, 57: 549-61.PubMedCrossRef
114.
Tang Y, Akbulut H, Maynard J, Petersen L, Fang X, Zhang WW, Xia X, Koziol J, Linton PJ, Deisseroth A: Vector prime/protein boost vaccine that overcomes defects acquired during aging and cancer. J Immunol. 2006, 177: 5697-707.PubMedCrossRef
115.
Grolleau-Julius A, Harning EK, Abernathy LM, Yung RL: Impaired dendritic cell function in aging leads to defective antitumor immunity. Cancer Res. 2008, 68: 6341-9.PubMedCentralPubMedCrossRef
116.
Leibovici J, Itzhaki O, Kaptzan T, Skutelsky E, Sinai J, Michowitz M, Asfur R, Siegal A, Huszar M, Schiby G: Designing ageing conditions in tumour microenvironment-A new possible modality for cancer treatment. Mech Ageing Dev. 2008
117.
Messaoudi I, Warner J, Fischer M, Park B, Hill B, Mattison J, Lane MA, Roth GS, Ingram DK, Picker LJ, Douek DC, Mori M, Nikolich-Zugich J: Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates. Proc Natl Acad Sci USA. 2006, 103: 19448-53.PubMedCentralPubMedCrossRef
118.
Woods JA, Ceddia MA, Wolters BW, Evans JK, Lu Q, McAuley E: Effects of 6 months of moderate aerobic exercise training on immune function in the elderly. Mech Ageing Dev. 1999, 109: 1-19.PubMedCrossRef
119.
Mysliwska J, Trzonkowski P, Szmit E, Brydak LB, Machala M, Mysliwski A: Immunomodulating effect of influenza vaccination in the elderly differing in health status. Exp Gerontol. 2004, 39: 1447-58.PubMedCrossRef
120.
Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, Brydak LB, Machala M, Mysliwski A: Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination – an impact of immunosenescence. Vaccine. 2003, 21: 3826-36.PubMedCrossRef
121.
Berzins SP, Uldrich AP, Sutherland JS, Gill J, Miller JF, Godfrey DI, Boyd RL: Thymic regeneration: teaching an old immune system new tricks. Trends Mol Med. 2002, 8: 469-76.PubMedCrossRef
122.
Sempowski GD, Gooding ME, Liao HX, Le PT, Haynes BF: T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol Immunol. 2002, 38: 841-8.PubMedCrossRef
123.
Nobori S, Shimizu A, Okumi M, Samelson-Jones E, Griesemer A, Hirakata A, Sachs DH, Yamada K: Thymic rejuvenation and the induction of tolerance by adult thymic grafts. Proc Natl Acad Sci USA. 2006, 103: 19081-6.PubMedCentralPubMedCrossRef
124.
Markert ML, Boeck A, Hale LP, Kloster AL, McLaughlin TM, Batchvarova MN, Douek DC, Koup RA, Kostyu DD, Ward FE, Rice HE, Mahaffey SM, Schiff SE, Buckley RH, Haynes BF: Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med. 1999, 341: 1180-9.PubMedCrossRef
125.
Phillips JA, Brondstetter TI, English CA, Lee HE, Virts EL, Thoman ML: IL-7 gene therapy in aging restores early thymopoiesis without reversing involution. J Immunol. 2004, 173: 4867-74.PubMedCrossRef
126.
Min D, Panoskaltsis-Mortari A, Kuro O, Hollander GA, Blazar BR, Weinberg KI: Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood. 2007, 109: 2529-37.PubMedCentralPubMedCrossRef
127.
Yajima N, Sakamaki K, Yonehara S: Age-related thymic involution is mediated by Fas on thymic epithelial cells. Int Immunol. 2004, 16: 1027-35.PubMedCrossRef
128.
Kumar R, Langer JC, Snoeck HW: Transforming growth factor-beta2 is involved in quantitative genetic variation in thymic involution. Blood. 2006, 107: 1974-9.PubMedCentralPubMedCrossRef
129.
Petrovas C, Casazza JP, Brenchley JM, Price DA, Gostick E, Adams WC, Precopio ML, Schacker T, Roederer M, Douek DC, Koup RA: PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med. 2006, 203: 2281-92.PubMedCentralPubMedCrossRef
130.
Riley JL, June CH: The road to recovery: translating PD-1 biology into clinical benefit. Trends Immunol. 2007, 28: 48-50.PubMedCrossRef
131.
Jimenez M, Martinez C, Ercilla G, Carreras E, Urbano-Ispizua A, Aymerich M, Villamor N, Amezaga N, Rovira M, Fernandez-Aviles F, Montserrat E: Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults. Transpl Immunol. 2006, 16: 52-9.PubMedCrossRef
132.
Lesourd B: Nutrition: a major factor influencing immunity in the elderly. J Nutr Health Aging. 2004, 8: 28-37.PubMed
133.
Marko MG, Ahmed T, Bunnell SC, Wu D, Chung H, Huber BT, Meydani SN: Age-associated decline in effective immune synapse formation of CD4(+) T cells is reversed by vitamin E supplementation. J Immunol. 2007, 178: 1443-9.PubMedCrossRef
134.
Albers R, Wielen van der RP, Brink EJ, Hendriks HF, Dorovska-Taran VN, Mohede IC: Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr. 2003, 57: 595-603.PubMedCrossRef
135.
Larbi A, Douziech N, Dupuis G, Khalil A, Pelletier H, Guerard KP, Fulop T: Age-associated alterations in the recruitment of signal-transduction proteins to lipid rafts in human T lymphocytes. J Leukoc Biol. 2004, 75: 373-81.PubMedCrossRef
136.
Duffy D, Rader DJ: Drugs in development: targeting high-density lipoprotein metabolism and reverse cholesterol transport. Curr Opin Cardiol. 2005, 20: 301-6.PubMedCrossRef
137.
Foody JM, Rathore SS, Galusha D, Masoudi FA, Havranek EP, Radford MJ, Krumholz HM: Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction. J Am Geriatr Soc. 2006, 54: 421-30.PubMedCentralPubMedCrossRef
138.
Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Lofgren S, Ernerudh J, Pawelec G, Ferguson F, Johansson B: The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev. 2006, 127: 695-704.PubMedCrossRef
139.
Leng SX, Xue QL, Tian J, Walston JD, Fried LP: Inflammation and frailty in older women. J Am Geriatr Soc. 2007, 55: 864-71.PubMedCrossRef
140.
Kim HJ, Barajas B, Chan RC, Nel AE: Glutathione depletion inhibits dendritic cell maturation and delayed-type hypersensitivity: Implications for systemic disease and immunosenescence. J Allergy Clin Immunol. 2007, 119: 1225-33.PubMedCrossRef
141.
Effros RB, Walford RL, Weindruch R, Mitcheltree C: Influences of dietary restriction on immunity to influenza in aged mice. J Gerontol. 1991, 46: B142-B147.PubMedCrossRef
142.
Wikby A, Johansson B, Ferguson F, Olsson J: Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol. 1994, 29: 531-41.PubMedCrossRef
143.
Pawelec G, Ferguson FG, Wikby A: The SENIEUR protocol after 16 years. Mech Ageing Dev. 2001, 122: 132-4.PubMedCrossRef
144.
Huppert FA, Pinto EM, Morgan K, Brayne C: Survival in a population sample is predicted by proportions of lymphocyte subsets. Mech Ageing Dev. 2003, 124: 449-51.PubMedCrossRef
145.
Peres A, Bauer M, da CI, Nardi NB, Chies JA: Immunophenotyping and T-cell proliferative capacity in a healthy aged population. Biogerontology. 2003, 4: 289-96.PubMedCrossRef
146.
Maury S, Mary JY, Rabian C, Schwarzinger M, Toubert A, Scieux C, Carmagnat M, Esperou H, Ribaud P, Devergie A, Guardiola P, Vexiau P, Charron D, Gluckman E, Socie G: Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol. 2001, 115: 630-41.PubMedCrossRef
147.
Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG: Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev. 2000, 121: 187-201.PubMedCrossRef
148.
Nilsson BO, Ernerudh J, Johansson B, Evrin PE, Lofgren S, Ferguson FG, Wikby A: Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols. Mech Ageing Dev. 2003, 124: 469-76.PubMedCrossRef
149.
Lang A, Brien JD, Messaoudi I, Nikolich-Zugich J: Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication. J Immunol. 2008, 180: 4848-57.PubMedCentralPubMedCrossRef
150.
Colonna-Romano G, Akbar AN, Aquino A, Bulati M, Candore G, Lio D, Ammatuna P, Fletcher JM, Caruso C, Pawelec G: Impact of CMV and EBV seropositivity on CD8 T lymphocytes in an old population from West-Sicily. Exp Gerontol. 2007, 42 (10): 995-1002.PubMedCrossRef
151.
Salvadori S, Martinelli G, Zier K: Resection of solid tumors reverses T cell defects and restores protective immunity. J Immunol. 2000, 164: 2214-20.PubMedCrossRef
152.
Battiwalla M, Wu Y, Bajwa RP, Radovic M, Almyroudis NG, Segal BH, Wallace PK, Nakamura R, Padmanabhan S, Hahn T, McCarthy PL: Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis. Biol Blood Marrow Transplant. 2007, 13: 765-70.PubMedCrossRef
153.
Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW: Herpesvirus latency confers symbiotic protection from bacterial infection. Nature. 2007, 447: 326-9.PubMedCrossRef
154.
Van BD, May L, Meij HJ, Westendorp RG: Regulation of human life histories: the role of the inflammatory host response. Ann N Y Acad Sci. 2007, 1100: 84-97.CrossRef
155.
Provinciali M, Smorlesi A: Immunoprevention and immunotherapy of cancer in ageing. Cancer Immunol Immunother. 2005, 54: 93-106.PubMedCrossRef
156.
157.
Qin W, Jiang J, Chen Q, Yang N, Wang Y, Wei X, Ou R: CpG ODN enhances immunization effects of hepatitis B vaccine in aged mice. Cell Mol Immunol. 2004, 1: 148-52.PubMed
158.
Blank C, Mackensen A: Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunol Immunother. 2007, 56: 739-45.PubMedCrossRef
159.
Provinciali M, Di SG, Colombo M, Della CF, Gandolfi MC, Daghetta L, Anichini M, Della BR, Fabris N: Adjuvant effect of low-dose interleukin-2 on antibody response to influenza virus vaccination in healthy elderly subjects. Mech Ageing Dev. 1994, 77: 75-82.PubMedCrossRef
160.
Ben-Yehuda A, Joseph A, Barenholz Y, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Galprin I, Gluck R, Zurbriggen R, Kedar E: Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents. Vaccine. 2003, 21: 3169-78.PubMedCrossRef
161.
162.
Haynes L, Eaton SM, Swain SL: Effect of age on naive CD4 responses: impact on effector generation and memory development. Springer Semin Immunopathol. 2002, 24: 53-60.PubMedCrossRef
163.
Clise-Dwyer K, Huston GE, Buck AL, Duso DK, Swain SL: Environmental and intrinsic factors lead to antigen unresponsiveness in CD4(+) recent thymic emigrants from aged mice. J Immunol. 2007, 178: 1321-31.PubMedCrossRef
164.
Haynes L, Eaton SM, Burns EM, Rincon M, Swain SL: Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. J Immunol. 2004, 172: 5194-9.PubMedCentralPubMedCrossRef
165.
Pfister G, Weiskopf D, Lazuardi L, Kovaiou RD, Cioca DP, Keller M, Lorbeg B, Parson W, Grubeck-Loebenstein B: Naive T cells in the elderly: are they still there?. Ann N Y Acad Sci. 2006, 1067: 152-7.PubMedCrossRef
166.
Herndler-Brandstetter D, Schwaiger S, Veel E, Fehrer C, Cioca DP, Almanzar G, Keller M, Pfister G, Parson W, Wurzner R, Schonitzer D, Henson SM, Aspinall R, Lepperdinger G, Grubeck-Loebenstein B: CD25-expressing CD8+ T cells are potent memory cells in old age. J Immunol. 2005, 175: 1566-74.PubMedCrossRef
167.
Metadata
Title
Immunity, ageing and cancer
Authors
Evelyna Derhovanessian
Rafael Solana
Anis Larbi
Graham Pawelec
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2008
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/1742-4933-5-11

Other articles of this Issue 1/2008

Immunity & Ageing 1/2008 Go to the issue

Short report

Hemostasis and ageing

Short report

Smoking, health and ageing

Short report

Alzheimer's disease: new diagnostic and therapeutic tools

Research

Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people

Research

Aged B lymphocytes retain their ability to express surface markers but are dysfunctional in their proliferative capability during early activation events

Research

Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits